🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pr. francis berenbaum, our CEO/CMO, showcased a presentation entitled «Pioneering Innovation in Osteoarthritis Treatment for Patients» at CHINABio. It was a pleasure for us. #biotech #4P004 #Innovation #OsteoarthritisTreatment #CHINABio #4PPharma

4Moving Biotech is thrilled to announce the successful completion of its Phase I recruitment clinical trial in patients with knee osteoarthritis. For more details: bit.ly/3tDPUfJ #4MovingBiotech #liraglutide #4P004 #Osteoarthritis #ClinicalTrials #Biotechnology

[#PrixGalienUS] Our company is honored to have been nominated in the “Best Startup” category for the 2023 #PrixGalienUS. #biotech #startup #BestStartup #osteoarthritis #GLP1 #liraglutideIntraarticualire #4P004 #frenchheathcare #PrixGalien

[#GalaArthritis] Nous avons le plaisir de participer au « GALA Arthritis 2023 » le lundi 13 novembre au Pavillon Cambon, Paris. Une soirée organisée par la Fondation Arthritis. #biotech #pharma #Arthrose #4P004 #musculosquelettiques #GalaArthritis2023 #rhumatismes

4Moving Biotech announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial. For more details: bwnews.pr/473utU8 #biotech #liraglutide #4P004 #Osteoarthritis #firstinclass #GLP1

4Moving Biotech announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial. For more details: (lien) #biotech #liraglutide #4P004 #Osteoarthritis #firstinclass #GLP1

Explore the insightful interview with our Chairwoman, Revital Rattenbach, on the Globaldata website! She discusses the significant milestones in 4Moving Biotech's clinical trial, our osteoarthritis asset. #Biotech #ClinicalTrials #Osteoarthritis #GlobalDataInterview

4Moving Biotech sera présent au 36e congrès de la Société Française de Rhumatologie, du 10 au 12 décembre 2023 à la Porte de Versailles. Le Pr francis berenbaum, notre Directeur médical partagera nos dernières avancées dans l'arthrose du genou. #Biotech #4P004 #Rhumatologie

We are excited to be part of the 42nd Annual #JPMweek in San Francisco, US, from 8 to 10 January, 2024. Our CEO Revital Rattenbach and 4Moving Biotech Corporate Business Development, Luc Boblet are delighted to connect with you in person at the event. #biotech #pharma #4P004 #GLP1

4Moving Biotech wishes you an incredible year of 2024 filled with success, achievement, and unforgettable moments.

4Moving Biotech is pleased to announce its sponsorship of the Osteoarthritis Research Society International (OARSI) Congress in Vienna, Austria, April 18-21. #Biotech #4P004 #clinicaltrial #OARSI

Félicitations à 4Moving Biotech, nommée parmi les "100 start-up où investir en 2024” par Challenges ! 👏👏 👉 Issue de la recherche académique, 4Moving Biotech a été cofondée par le professeur Francis Berenbaum (francis berenbaum) et soutenue par SATTLutech : challenges.fr/start-up/4movi…

Félicitations à 4Moving Biotech cofondée par Francis Berenbaum, Professeur de rhumatologie à Hôpital Saint-Antoine AP-HP, nommée l’une des « 100 Start-up où investir en 2024 » par le magazine Challenges pour son innovation dans le traitement de l'#arthrose 👏

[#OARSI2024] Our CMO, Professor @larumatho, will deliver an oral presentation on Friday, April 19, 2024, during the OARSI 2024 Clinical Trial Symposium. Coralie Meurot, our preclinical researcher scientist, will present her poster during the congress poster presentation session.

We are thrilled to announce that Professor francis berenbaum, Chief Medical Officer of 4Moving Biotech, is invited to speak at the EULAR congress, which will take place from June 12 to 15 in Vienna. 🎙️Title of lecture: “ Disease-Modifying OA Drugs: Are We There Yet?” #EULAR2024

4Moving Biotech is delighted to announce successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients. Read the Press release here: businesswire.com/news/home/2024… #osteoarthritis #4P004 #biotech #frenchtech

Join us for the 18th Annual Conference of the International Society of OsteoArthritis Imaging, scheduled for Wednesday, June 26, 2024, in Marrocco! Professor francis berenbaum, our Chief Medical Officer, will share his expertise on "Synovitis and OA Pain". #osteoarthritis #IWOAI

We are thrilled to announce that Luc Boblet joins 4Moving Biotech as its Chief Executive Officer. Luc is a seasoned biotech entrepreneur with a demonstrated track record of building biotech ventures. To read the Press Release👉: businesswire.com/news/home/2024… #Biotech #4P004

4Moving Biotech a le plaisir d'annoncer sa participation à la 11e édition du « GALA Arthritis ». Une soirée organisée par la Fondation Arthritis, visant à soutenir l’émergence d’une recherche française de qualité sur les rhumatismes et maladies musculo-squelettiques. #biotech

We are thrilled to announce that Professor francis berenbaum will be attending the annual American College of Rheumatology conference hashtag#ACR from November 14 to 19. #ACR #Rheumatology #Osteoarthritis #Innovation #Research